Xtant Medical Holdings Inc (XTNT) Earnings Report, Financial Results, Financial analysis

Xtant Medical Holdings Inc narrowed III. Quarter net loss per share of $-0.02 compare to net loss per share of $-0.10 recorded in the same quarter a year ago a decrease compare to $-0.01 realized in previous quarter.

*III. Quarter*
Earnings Per Share	Revenues
$ -0.02	$ 14 Mill
$+0.08	Unch. -1.71 %

Xtant Medical Holdings Inc 's Revenue fell by -1.71 % in III. Quarter (Sep 30 2021) year on year, to $14 million and declined by -8 % sequentially.

Xtant Medical Holdings Inc is Expected to report next financial results on February 23, 2022.

More on XTNT's Income Statement

XTNT's NET INCOME

Xtant Medical Holdings Inc 's in III. Quarter recorded net loss of $-2 million, an increase from net loss of $-1 million in III. Quarter a year ago.

Sequentially net loss advanced

More on XTNT's Growth

Inventories declined by -4.66 % to $19.71 million from III. Quarter a year ago, sequentially inventories fell by -6.57 %. In III. Quarter company's net cash and cash equivalents decreased by $-2 million, capital expenditures fell by 75.21%, to $-0 millions compare to same quarter a year ago and rose by -23.65% from II. Quarter (Jun 30 2021).

More on XTNT's Cash flow Statement

Earnings quality

Xtant Medical Holdings Inc does not pay out common stock dividend.

In trailing twelve-month period Xtant Medical Holdings Inc earned $ 0.01 cash per share, on a free-cash flow basis .

Book value fell by -3.74 % sequentially to $0.38 per share, -37.03% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.33 per share from $ 0.35.

Company issued 0.06 million shares or 0.06 % in III. Quarter.

• More on XTNT's Dividends

Market Capitalization (Millions)	55
Shares Outstanding (Millions)	87
Total Debt (Millions $)	15
Revenue (TTM) (Millions $)	55
Net Income (TTM) (Millions $)	-3
Cash Flow (TTM) (Millions $)	16
Capital Exp. (TTM) (Millions $)	-2
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Earnings quality

• More on XTNT's Balance Sheets

Market Capitalization (Millions)	55
Shares Outstanding (Millions)	87
Total Debt (Millions $)	15
Revenue (TTM) (Millions $)	55
Net Income (TTM) (Millions $)	-3
Cash Flow (TTM) (Millions $)	16
Capital Exp. (TTM) (Millions $)	-2
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar DLTH's Profile Stock Price DLTH's Financials Business Description Fundamentals Charts & Quotes DLTH's News Suppliers DLTH's Competitors Customers & Markets Economic Indicators DLTH's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Xtant Medical Holdings Inc

XTNT's Financial Statements and Analysis